No secondary impact of ivermectin mass drug administration for onchocerciasis elimination on the prevalence of scabies in northwestern Ethiopia.
Robel YirguJo MiddletonAbebaw FekaduGail DaveyStephen BremnerChristopher Iain JonesJackie A CassellPublished in: Transactions of the Royal Society of Tropical Medicine and Hygiene (2023)
Ivermectin MDA for onchocerciasis was not observed to have a secondary impact on the prevalence of scabies over the follow-up period of 12 months.